TransMedics Group, Inc. (TMDX) Earnings Call Analysis
NASDAQ · Healthcare · Medical Devices
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
TransMedics (TMDX) Q1 2026: R&D Investment Surges 45% as Gen 3.0 and CHOPS Expand TAM
May 06, 2026
-
TransMedics (TMDX) Q4 2025: OCS Liver Share Jumps to 36%, Expanding U.S. Transplant Market
February 25, 2026
-
TransMedics (TMDX) Q3 2025: Logistics Revenue Climbs 35% as EU Expansion Takes Shape
October 29, 2025
-
TransMedics (TMDX) Q2 2025: Operating Margin Expands 650bps as OCS Adoption Drives Scale
July 30, 2025
-
TransMedics (TMDX) Q1 2025: Liver Drives 48% Revenue Surge as OCS Platform Expands Clinical Lead
July 05, 2025